Evidence map›Paper›PMID 30285677›Full record

ArticleBMC cancer2018

Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.

Kar-Tong Tan, Ling-Wen Ding, Qiao-Yang Sun, Zhen-Tang Lao, Wenwen Chien, Xi Ren, Jin-Fen Xiao, Xin Yi Loh, Liang Xu, Michael Lill and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Kar-Tong TanCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Ling-Wen DingCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. csidlw@nus.edu.sg.ORCID http://orcid.org/0000-0003-0022-1551
Qiao-Yang SunCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Zhen-Tang LaoCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Wenwen ChienDivision of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, USA.
Xi RenCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Jin-Fen XiaoCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Xin Yi LohCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Liang XuCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Michael LillDivision of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, USA.
Anand MayakondaCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
De-Chen LinDivision of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, USA.
Henry YangCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. csiyangh@nus.edu.sg.
H Phillip KoefflerCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
National University of Singapore · SGCedars-Sinai Medical Center · US

Funding

Ministry of Health -Singapore NMRC/STaR/0021/2014
6 · The paper itself

Abstract

backgroundClonal VDJ rearrangement of B/T cell receptors (B/TCRs) occurring during B/T lymphocyte development has been used as a marker to track the clonality of B/T cell populations.

methodsWe systematically profiled the B/T cell receptor repertoire of 936 cancer cell lines across a variety of cancer types as well as 462 Epstein-Barr Virus (EBV) transformed normal B lymphocyte lines using RNA sequencing data.

resultsRearranged B/TCRs were readily detected in cell lines derived from lymphocytes, and subclonality or potential biclonality were found in a number of blood cancer cell lines. Clonal BCR/TCR rearrangements were detected in several blast phase CML lines and unexpectedly, one gastric cancer cell line (KE-97), reflecting a lymphoid origin of these cells. Notably, clonality was highly prevalent in EBV transformed B lymphocytes, suggesting either transformation only occurred in a few B cells or those with a growth advantage dominated the transformed population through clonal evolution.

conclusionsOur analysis reveals the complexity and heterogeneity of the BCR/TCR rearrangement repertoire and provides a unique insight into the clonality of lymphocyte derived cell lines.

Indexed as

B-LymphocytesCell Line, TumorHematologic NeoplasmsHerpesvirus 4, HumanHumansLymphocytesNeoplasmsReceptors, Antigen, B-CellReceptors, Antigen, T-CellRNAReceptors, Antigen, B-CellReceptors, Antigen, T-CellRNABCR/TCR receptor repertoireCancer cell linesEBV lymphocytes

Identifiers

PMID30285677
PMCPMC6167786
OpenAlexW2894185742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.